The Journal of Pathology: Clinical Research, 2056-4538

Tidskrift

Fler filtreringsmöjligheter
  1. 2020
  2. Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma

    Karim H. Saba, Louise Cornmark, Jakob Hofvander, Linda Magnusson, Jenny Nilsson, Hilda van den Bos, Diana C.J. Spierings, Floris Foijer, Johan Staaf, Otte Brosjö, Vaiyapuri P. Sumathi, Suk Wai Lam, Karoly Szuhai, Judith V.M.G. Bovée, Michal Kovac, Daniel Baumhoer, Emelie Styring & Karolin H. Nord, 2020, I : Journal of Pathology: Clinical Research.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. NTRK fusions in osteosarcoma are rare and non-functional events

    Baptiste Ameline, Karim H. Saba, Michal Kovac, Linda Magnusson, Olaf Witt, Stefan Bielack, Michaela Nathrath, Karolin H. Nord & Daniel Baumhoer, 2020, I : Journal of Pathology: Clinical Research.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. 2017
  5. Multi-parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour-type-specific stroma phenotypes and a novel vascular biomarker

    Sara Corvigno, Magnus Frödin, G Bea A Wisman, Hans W Nijman, Ate GJ Van der Zee, Karin Jirström, Björn Nodin, Ina Hrynchyk, David Edler, Peter Ragnhammar, Martin Johansson, Hanna Dahlstrand, Artur Mezheyeuski & Arne Östman, 2017 jun 13, I : The Journal of Pathology: Clinical Research. 3, 3, s. 214-224 11 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer

    J. Paulsson, Lisa Rydén, C Strell, O Frings, Nicholas P Tobin, T. Fornander, J. Bergh, Göran Landberg, O. Ståhl & A. Östman, 2017 jan, I : The Journal of Pathology: Clinical Research. 3, 1, s. 38-43

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift